Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Camostat Mesylate for Kidney Protection in CKD
NCT06794593Phase 2Recruiting
- Sponsor
- University Hospital Odense
- Start
- Nov 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of camostat mesilate in chronic kidney disease (CKD), sponsored by University Hospital Odense. Started Nov 2024; status: recruiting.
02
Drugs
camostat mesilate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT06794593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06794593.